“CS mold” is a new threat in India as the second COVID wave shakes | Coronavirus epidemic News:

As the devastating second wave of COVID-19 tremors was reported on Tuesday, with more than 100,000 new cases reported, India is now battling a new fear. The mucous membrane, commonly referred to as the “fungus”, is a rare fungal disease with a high mortality rate.

On Monday, Health Minister Harsh Vardan said more than 28,000 cases of fungal infections had been reported in the country.

“We have 28,252 mucosal cases from 28 states so far. “86 percent of them, or 24,370 cases, have a history of COVID-19, and 62.3 percent, or 17,601, have a history of diabetes,” Vartan said during a meeting with a group of federal ministers.

“The highest number of cases, 6,329, was in Maharashtra, followed by Gujarat (5,486), followed by Madhya Pradesh, Uttar Pradesh, Rajasthan, Haryana, Karnataka, Delhi and Andhra Pradesh,” he said.

What is black mold?

Mucormycosis causes darkening or discoloration of the nose, blurred or double vision, chest pain, difficulty breathing և blood cough. Coronaviruses with diabetes հարձակ weakened immune system are particularly prone to attack.

Pain and redness in the eye or nose, fever, headache, cough, shortness of breath, bloody vomiting փոփոխ Mental state changes are some of the symptoms.

Patients infected with black mold at Hyderabad State Hospital [File: Mahesh Kumar A/AP]

Health experts say poor air quality in India և In cities like Mumbai, excess dust facilitates the growth of fungi, calling the latest case of “serious concern”.

“We have seen more mucosal cases in most major hospitals in the last month than in the previous five years,” Dr. Arvinder Soin, president of the Meduga Liver Transplant Institute in Gurugram, told Al Jazeera.

While black fungus has been found in India in the past, the current increase in infections is among people recovering from COVID-19 infection.

Dr Sumit Mrig, head of the ENT department at Max Smart Super Specialty Hospital in New Delhi, told Al Jazeera that he had seen one or two such cases in the week before the second wave of the epidemic.

“This time the numbers have risen sharply, and now we see five to six such patients a day,” Mrig said.

He said the outbreak had “put a huge strain on healthcare infrastructure”, especially on the latest in a series of liposomal Amphotericin-B drugs used to treat black mold, which he said was “suddenly in short supply in the country”. ,

“Apart from the high mortality associated with the disease, which spreads rapidly from the nasopharyngeal sinuses to the eye and brain for 24 to 48 hours, if treatment is not started in time, the patient may lose his sight. “Mortality from brain involvement is about 80 percent,” Mrigg added.

How is the infection treated?

Liposomal Amphotericin-B is supplied to states by the federal government based on the number of cases they report.

A number of states have reported shortages of vital drugs as Indian missions around the world seek to secure supplies. Last week, India imposed restrictions on exports of Amphotericin-B injections.

Opposition parties, including the Congress, have questioned Prime Minister Narendra Modi over fears of mushrooms.

“What is being done for amphotericin B deficiency?” What is the procedure for getting this medicine to a patient? ” Last week, Congress leader Rahul Gandhi tweeted:

“Instead of treatment, why is the society entangled in the government’s greed?” he posted.

A doctor performs endoscopic sinus surgery on a patient suffering from mucormycosis at Haz Aziabad Private Hospital on the outskirts of New Delhi. [Adnan Abidi/Reuters]

Also last week, the Delhi High Court instructed the federal government to develop a policy on the distribution of Liposomal Amphotericin B.

The court ruled that the use of the drug should be a “priority” for those who “have a better chance of survival, like the offspring with a promise of a future than the older ones who have lived their lives.”

“Steroids make the situation worse”

Soin, a doctor at Medanta Hospital, said that fungal infections during the second wave of COVID affect coronavirus patients three to six weeks after recovery, most often those with uncontrolled diabetes or being treated with steroids.

“Although steroids are life-saving for many patients with COVID, many cases could have been prevented if their diabetes had been better controlled and steroid use limited,” he told Al Jazeera.

Dr. Ay Ayraprakash Muliil, an epidemiologist at the Christian Medical College in the southern state of Tamil Nadu, said that irregularity in attending patients with diabetes is a possible cause of mucositis.

“When a patient is diabetic, he / she is admitted to the ward, usually having a double blood sugar test, adjusting the dose of any medication needed to control it. But during COVID, these records are not fully complied with in many hospitals. That could be one of the reasons, “he said.

“When blood sugar gets out of control, they do [patients] They are on steroids, which makes the situation worse. “

Experts believe that high-risk diabetics who have recovered from COVID-19 should be cautious և Any red flag should be reported immediately to an ENT surgeon.

“If we control the blood sugar of COVID-19 patients, I believe you will not have this problem, we can do it.” Dr. Muliil said.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button